NCT06381232

Brief Summary

The purpose of the study is to collect and analyze physiological, physical, and molecular data from a diverse population to increase our understanding of how such parameters are associated with health and disease.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20,000

participants targeted

Target at P75+ for all trials

Timeline
27mo left

Started Jul 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Jul 2018Jul 2028

Study Start

First participant enrolled

July 23, 2018

Completed
5.7 years until next milestone

First Submitted

Initial submission to the registry

April 18, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 24, 2024

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 23, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 23, 2028

Last Updated

April 24, 2024

Status Verified

March 1, 2024

Enrollment Period

10 years

First QC Date

April 18, 2024

Last Update Submit

April 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Molecular Determinants of Health and Disease

    We measure thousands of transcript levels in multiple clinical samples. The primary outcome measures are changes in quantitative gene expression, microbial or human, as a result of transitioning from a healthy state to a disease.

    10 years

Study Arms (2)

Healthy Control

Other: No Intervention

Cases (Various Phenotypes)

Other: No Intervention

Interventions

This is an observational study, there are no interventions.

Cases (Various Phenotypes)Healthy Control

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Participants with specific phenotypes of interest and matched healthy controls.

You may qualify if:

  • Anyone that resides in the US at the time of enrollment.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Viome Life Sciences

Bothell, Washington, 98011, United States

RECRUITING

Study Officials

  • Momchilo Vuyisich, PhD

    Viome

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Momchilo Vuyisich, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 18, 2024

First Posted

April 24, 2024

Study Start

July 23, 2018

Primary Completion (Estimated)

July 23, 2028

Study Completion (Estimated)

July 23, 2028

Last Updated

April 24, 2024

Record last verified: 2024-03

Locations